Assertio Therapeutics, Inc
Assertio Therapeutics, Inc (ASRT) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 264 transactions totaling $7.2M, demonstrating a bearish sentiment with -$6.4M in net insider flow. The most recent transaction on Feb 21, 2026 involved a transaction of 1,143 shares valued at $0.
ASRT Insider Activity Summary
Who Is Buying ASRT Stock?
No significant insider buying has been recorded for ASRT in the recent period.
Who Is Selling ASRT Stock?
No significant insider selling has been recorded for ASRT in the recent period.
Is Assertio Therapeutics, Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ASRT is bearish with an Insider Alignment Score of 6/100 and a net flow of -$6.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ASRT Frequently Asked Questions
Understanding ASRT Insider Activity
Insider trading at Assertio Therapeutics, Inc (ASRT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading ASRT stock, having executed 264 transactions in the past 90 days. The most active insider is Daniel A. Peisert (Executive), who has made 63 transactions totaling $4.4M.
Related Tools
Track Assertio Therapeutics, Inc Insider Activity
Get notified when executives and directors at ASRT file new Form 4 transactions